patient populations

(University of Pittsburgh Schools of the Health Sciences) How often patients receive surveillance colonoscopy may need to be better aligned with their risks for colorectal cancer, according to two papers published this month by University of Pittsburgh School of Medicine researchers.

The studies provide evidence that colonoscopy is both overused and underused in particular patient populations with serious implications for health care spending.

We have repeatedly argued why comparative effectiveness research, under ideal circumstances, would be a good idea.  As I said before:

We have tried to argue why comparative effectiveness research is a good idea. To cut and paste what I wrote in a previous post,

(University of Rochester Medical Center) A study conducted by the University of Rochester Medical Center demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment.

The implantable device, called Rheos, is in advanced stages of testing for individuals with drug resistant hypertension.

An experimental compound successfully reduced the risk of hip and spine fractures in two key patient populations: postmenopausal women and men being treated for prostate cancer

We have tried to argue why comparative effectiveness research is a good idea. To cut and paste what I wrote in a previous post,